Unit of Breast and Gynecologic Pathology, Department of Pathology, Medical University of Graz, Austria
Abstract
This review deals with studies that have used cDNA microarrays and immunohistochemistry to identify a subtype of breast carcinoma recently known as “basal-like” carcinoma. The key breast carcinoma studies are critically discussed to highlight methodological problems in cohort selection, definitions, interpretation of results, and statistical analysis. It concludes that “basal-like” carcinomas do not reflect a single, biologically uniform group of breast cancers and show significant variations in their phenotypes, grades, immunoprofiles, and clinical behavior, just as a wide range of subtypes and behaviors is observed among epithelial/luminal-derived breast carcinomas. Welldesigned studies with comparison of low grade non-basal versus low grade basal and high grade non-basal versus high grade basal carcinomas are necessary before one can be convinced that this subtype represents a distinct clinicopathologic entity.
Moinfar,F. (2007). Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes. Iranian Journal of Pathology, 2(4), 127-143.
MLA
Moinfar,F. . "Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes", Iranian Journal of Pathology, 2, 4, 2007, 127-143.
HARVARD
Moinfar F. (2007). 'Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes', Iranian Journal of Pathology, 2(4), pp. 127-143.
CHICAGO
F. Moinfar, "Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes," Iranian Journal of Pathology, 2 4 (2007): 127-143,
VANCOUVER
Moinfar F. Is “Basal-like” Carcinoma of the Breast a Distinct Clinicopathologic Entity? A Critical Review with Cautionary Notes. Iran J Pathol, 2007; 2(4): 127-143.